Gilead Sciences to Present at Two Upcoming Investor Conferences
June 02 2009 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the William Blair 29th Annual Growth
Stock Conference in Chicago and the Goldman Sachs 30th Annual
Global Healthcare Conference in New York.
Kevin Young, Gilead�s Executive Vice President of Commercial
Operations, will provide an overview of the company at the William
Blair conference on Tuesday, June 9 at 3:10 p.m. CDT (4:10 p.m.
EDT).
John F. Milligan, PhD, Gilead�s President and Chief Operating
Officer, will provide an overview of the company at the Goldman
Sachs conference on Thursday, June 11 at 10:20 a.m. EDT.
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company�s website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company's mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead
Sciences, please visit www.gilead.com or call the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024